RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RUBINI E
Collezione ASL Città di Torino

Items : 15

The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study. in Nutrients / Nutrients. 2024 Nov 29;16(23):4132. doi: 10.3390/nu16234132.

2024
ASL Città di Torino

Sciascia S; Ferrara G; Roccatello L; Rubini E; Foddai SG; Radin M; Cecchi I; Rossi D; Barinotti A; Ricceri F; Gilcrease W; Baldovino S; Ferreira Poshar A; Conti A; Fenoglio R;

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.

2023
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D; Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D;

Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.

2023
ASL Città di Torino

Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D; Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D;

Daratumumab monotherapy for refractory lupus nephritis. in Nature medicine / Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10.

2023
ASL Città di Torino

Roccatello D; Fenoglio R; Caniggia I; Kamgaing J; Naretto C; Cecchi I; Rubini E; Rossi D; De Simone E; Del Vecchio G; Cozzi M; Sciascia S;

Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis

2022
ASL Città di Torino

Sciascia S; Foddai SG; Alessandri C; Alunno A; Andreoli L; Barinotti A; Calligaro A; Canti V; Carubbi F; Cecchi I; Chighizola CB; Conti F; Emmi G; Fioravanti A; Fischetti F; Franceschini F; Gerosa M; Hoxha A; Larosa M; Lazzaroni MG; Nalli C; Pazzola G; Radin M; Raffeiner B; Ramoni VL; Rubini E; Sebastiani GD; Truglia S; Urban ML; et alii...

Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):e1. doi: 10.1055/s-0043-1769787. Epub 2023 May 24.

2022
ASL Città di Torino

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.

2022
ASL Città di Torino

Foddai SG; Cecchi I; Rubini E; Radin M; Barinotti A; Rossi D; Sciascia S; Roccatello D;

The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1071-1076. doi: 10.55563/clinexprheumatol/c96ief. Epub 2020 N

2021
ASL Città di Torino

Schreiber K; Radin M; Cecchi I; Rubini E; Roccatello D; Jacobsen S; Cuadrado MJ; Sciascia S;

Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. in Lupus / Lupus. 2021 May;30(6):884-892. doi: 10.1177/0961203321995248. Epub 2021 Feb 16.

2021
ASL Città di Torino

Cecchi I; Radin M; Rubini E; Foddai SG; Barinotti A; Roccatello D; Sciascia S;

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.

2021
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Rossi D; Mengozzi G; Roccatello D; Bazzan M; Giachino O; Baldovino S; Vaccarino A; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Radin M; Sciascia S;

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2021 Jun 16;16(1):280. doi: 10.1186/s13023-021-01906-1.

2021
ASL Città di Torino

Radin M; Foddai SG; Barinotti A; Cecchi I; Rubini E; Sciascia S; Roccatello D;

Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology. in Thrombosis research / Thromb Res. 2021 Jun;202:100-103. doi: 10.1016/j.thromres.2021.03.019. Epub 2021 Mar 22.

2021
ASL Città di Torino

Radin M; Foddai S; Cecchi I; Rubini E; Barinotti A; Mahler M; Seaman A; Ramirez C; Casas S; Roccatello D; Sciascia S;

Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue Disease. in Arthritis care & research / Arthritis Care Res (Hoboken). 2021 Dec;73(12):1804-1808. doi: 10.1002/acr.24391. Epub 2021 Oct 4.

2021
ASL Città di Torino

Radin M; Schreiber K; Cecchi I; Bortoluzzi A; Crisafulli F; de Freitas CM; Bacco B; Rubini E; Foddai SG; Padovan M; Gallo Cassarino S; Franceschini F; Andrade D; Benedetto C; Govoni M; Bertero T; Marozio L; Roccatello D; Andreoli L; Sciascia S;

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.

2021
ASL Città di Torino

Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S;

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.

2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Rubini E; Foddai SG; Barinotti A; Vaccarino A; Rossi D; Roccatello D;